A-Alpha Bio is a synthetic biology and machine learning company that precisely engineers high-impact medicines by measuring millions of protein-protein interactions. Founded in 2017 as a spinout from the University of Washington, the company is based in Seattle.
Subscribe to see A-Alpha Bio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
A-Alpha Bio, Inc. is a biotechnology company headquartered in United States. It has raised at least $46.2M across the 4 funding rounds on record. Its most recent funding round, Series A2, raised $620,000 in March 2026. Xcout tracks 10 named people at A-Alpha Bio, Inc., including David Younger (Chief Executive Officer & Co-Founder). Xcout recorded 6 job postings from A-Alpha Bio, Inc. in the last 90 days, naming tools such as Salesforce.
4 more named people on record for A-Alpha Bio, Inc., with roles, board committees and tenure — see the full roster →
At least $46.2M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A2 | $620,000 | 4 named | |
| Series A2 | $22.4M | 3 named | |
| Grant | $20.3M | 2 named | |
| Seed | $2.8M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 6 job postings from A-Alpha Bio, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see A-Alpha Bio, Inc.'s hiring signals →
A few of A-Alpha Bio, Inc.'s closest competitors — see the full list of competitors and alternatives →
Noetik Inc. is an AI-native biotechnology company headquartered in South San Francisco, California, leveraging advanced machine learning methods for biological discovery.
Blank Bio is an applied AI research lab founded in 2025 and headquartered in San Francisco, California. The company builds RNA foundation models to learn patterns linked to disease, providing RNA intelligence for precision oncology and medicine.
Portal Biotech is a biotechnology company founded by DNA-sequencing veterans that leverages machine learning and nanopore expertise. The firm has built a specialized platform capable of sequencing full-length proteins at the single-molecule level.
Dyno Therapeutics is a biotechnology research company headquartered in Watertown, Massachusetts, specializing in gene therapy delivery solutions using artificial intelligence.
Shift Bioscience is a biotechnology research company based in Cambridge, United Kingdom, that employs generative AI virtual cell models to understand gene activation and cellular reprogramming.
SwitchPoint Bio Holding, Inc. operates a platform that combines precision epigenomics and artificial intelligence to analyze cellular biology from blood samples. The company provides biomarker discovery, patient stratification, and treatment response mechanism readouts to support drug development and clinical research.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about A-Alpha Bio, Inc.? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.